DFDA - Trademark Details
Status: 686 - Published For Opposition
Image for trademark with serial number 88564669
Serial Number
88564669
Word Mark
DFDA
Status
686 - Published For Opposition
Status Date
2022-01-04
Filing Date
2019-08-02
Mark Drawing
4000 - Standard character mark Typeset
Published for Opposition Date
2022-01-04
Law Office Assigned Location Code
M70
Employee Name
EUBANK, REBECCA A
Statements
Goods and Services
Dosage formulation development and analysis services, namely, pharmaceutical drug development services, testing services for pharmaceuticals, pharmaceutical products development, laboratory research services relating to pharmaceuticals, or testing, inspection or research of pharmaceuticals; Dosage formulation in the nature of pharmaceutical drug development services, pharmaceutical products development using Multi-Factor-At-a-Time strategies; Dosage formulation and analysis in the nature of pharmaceutical drug development services, pharmaceutical products development, testing services for pharmaceuticals, namely, developing different dose and delivery systems in the nature of oral solids in the nature of tablets, capsules, gummies, candy, pastes, powder blends; oral semi-solids in the nature of soft-gels, gels in the nature of oral liquids, tincture, syrup, sprays, sublingual sprays, and oral care liquids, vitamins, mineral drinks, and topical formulations such as dermal and transdermal creams, gels, lotions, and serums; Qualitative and quantitative analysis of key active compounds in pharmaceuticals, nutraceutical, cosmeceutical and therapeutic food products; Dosage and dose analysis in pharmaceuticals, nutraceutical, cosmeceutical and therapeutic food products to identify potency and strength of dosage; Forced degradation analysis of pharmaceuticals, nutraceutical, cosmeceutical and therapeutic food products to identify stability indication of the dosage, the shelf life determination
Goods and Services
Dosage formulation development and analysis services, namely, pharmaceutical drug development services, testing services for pharmaceuticals, pharmaceutical products development, laboratory research services relating to pharmaceuticals, and testing, inspection or research of pharmaceuticals; Dosage formulation in the nature of pharmaceutical drug development services, pharmaceutical products development using Multi-Factor-At-a-Time strategies; Dosage formulation and analysis in the nature of pharmaceutical drug development services, pharmaceutical products development, and testing services for pharmaceuticals, namely, developing different dose and delivery systems in the nature of oral solids in the nature of tablets, capsules, gummies, candy, pastes, powder blends, oral semi-solids in the nature of soft-gels, gels in the nature of oral liquids, tincture, syrup, sprays, sublingual sprays, and oral care liquids, vitamins, mineral drinks, and topical formulations in the nature of dermal and transdermal creams, gels, lotions, and serums; Scientific research services in the nature of qualitative and quantitative analysis of key active compounds in pharmaceuticals, nutraceutical, cosmeceutical and therapeutic food products; Pharmaceutical research services in the nature of dosage and dose analysis in pharmaceuticals, nutraceutical, cosmeceutical and therapeutic food products to identify potency and strength of dosage; Scientific research services in the nature of forced degradation analysis of pharmaceuticals, nutraceutical, cosmeceutical and therapeutic food products to identify stability indication of the dosage and the shelf life determination
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2019-08-21
Primary Code
042
Current Trademark Owners
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Francis John Ciaramella, Esquire
Address
Please log in with your Justia account to see this address.
Trademark Events
Event DateEvent Description
2019-08-21NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2019-09-27ASSIGNED TO EXAMINER
2019-10-02NON-FINAL ACTION WRITTEN
2019-10-02NON-FINAL ACTION E-MAILED
2019-10-02NOTIFICATION OF NON-FINAL ACTION E-MAILED
2020-04-02TEAS RESPONSE TO OFFICE ACTION RECEIVED
2020-04-09ASSIGNED TO LIE
2020-04-17CORRESPONDENCE RECEIVED IN LAW OFFICE
2020-04-17TEAS/EMAIL CORRESPONDENCE ENTERED
2020-04-21SUSPENSION LETTER WRITTEN
2020-04-21LETTER OF SUSPENSION E-MAILED
2020-04-21NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
2020-10-21SUSPENSION INQUIRY WRITTEN
2020-10-21INQUIRY TO SUSPENSION E-MAILED
2020-10-21NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
2021-04-20TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
2021-04-22CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-04-22TEAS/EMAIL CORRESPONDENCE ENTERED
2021-05-07NON-FINAL ACTION WRITTEN
2021-05-07NON-FINAL ACTION E-MAILED
2021-05-07NOTIFICATION OF NON-FINAL ACTION E-MAILED
2021-11-05TEAS RESPONSE TO OFFICE ACTION RECEIVED
2021-11-05CORRESPONDENCE RECEIVED IN LAW OFFICE
2021-11-06TEAS/EMAIL CORRESPONDENCE ENTERED
2021-11-30EXAMINERS AMENDMENT -WRITTEN
2021-11-30EXAMINERS AMENDMENT E-MAILED
2021-11-30NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
2021-11-30EXAMINER'S AMENDMENT ENTERED
2021-11-30APPROVED FOR PUB - PRINCIPAL REGISTER
2021-12-15NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2022-01-04PUBLISHED FOR OPPOSITION
2022-01-04OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED